These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. The role of photochemical treatment with amotosalen and UV-A light in the prevention of transfusion-transmitted cytomegalovirus infections. Roback JD; Conlan M; Drew WL; Ljungman P; Nichols WG; Preiksaitis JK Transfus Med Rev; 2006 Jan; 20(1):45-56. PubMed ID: 16373187 [TBL] [Abstract][Full Text] [Related]
13. New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes. Corash L Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):549-63. PubMed ID: 11102276 [TBL] [Abstract][Full Text] [Related]
14. The rationale for pathogen-inactivation treatment of blood components. Barbara JA Int J Hematol; 2004 Nov; 80(4):311-6. PubMed ID: 15615254 [TBL] [Abstract][Full Text] [Related]
16. [Transfusion-transmitted bacterial infection: residual risk and perspectives of prevention]. Morel P; Deschaseaux M; Bertrand X; Naegelen C; Talon D Transfus Clin Biol; 2003 Jun; 10(3):192-200. PubMed ID: 12798856 [TBL] [Abstract][Full Text] [Related]
17. Transfusion safety: Where are we today? Luban NL Ann N Y Acad Sci; 2005; 1054():325-41. PubMed ID: 16339681 [TBL] [Abstract][Full Text] [Related]
18. Transfusion transmitted infections in solid organ transplantation. Mezochow AK; Henry R; Blumberg EA; Kotton CN Am J Transplant; 2015 Feb; 15(2):547-54. PubMed ID: 25612502 [TBL] [Abstract][Full Text] [Related]
19. Ensuring safety of the blood supply in the United States: Donor screening, testing, emerging pathogens, and pathogen inactivation. Godbey EA; Thibodeaux SR Semin Hematol; 2019 Oct; 56(4):229-235. PubMed ID: 31836028 [TBL] [Abstract][Full Text] [Related]
20. Errors in transfusion medicine. Stainsby D Anesthesiol Clin North Am; 2005 Jun; 23(2):253-61, v. PubMed ID: 15922897 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]